miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome

Due to increasing prevalence of obesity, a simple method or methods for the diagnosis of metabolic syndrome are urgently required to reduce the risk of associated cardiovascular disease, diabetes and cancer. This study aimed to identify a miRNA biomarker that may distinguish metabolic syndrome from...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neill, Sadhbh, Larsen, Mette Bohl, Gregersen, Søren, Hermansen, Kjeld, O’Driscoll, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823618/
https://www.ncbi.nlm.nih.gov/pubmed/29507696
http://dx.doi.org/10.18632/oncotarget.24314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823618/
https://www.ncbi.nlm.nih.gov/pubmed/29507696
http://dx.doi.org/10.18632/oncotarget.24314

Ejemplares similares